Matches in Nanopublications for { ?s ?p "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP896502.RATC7AOQOsHNcIRImKIvd-Uh7xC_7VOuIGzvbBTWfxbJc130_assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896502.RATC7AOQOsHNcIRImKIvd-Uh7xC_7VOuIGzvbBTWfxbJc130_provenance.
- assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP926820.RAzE0CV7ECloh2b0Y94CbKz3_sm9FX44gDxLbUITF4g2Y130_assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926820.RAzE0CV7ECloh2b0Y94CbKz3_sm9FX44gDxLbUITF4g2Y130_provenance.
- NP363445.RAntuZ21lYe8ih6b4bsqtNRNQUM_VTf3umY7Ju4FxLmTk130_assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363445.RAntuZ21lYe8ih6b4bsqtNRNQUM_VTf3umY7Ju4FxLmTk130_provenance.
- NP251489.RAm6F0jMft8kxIYHCqsRv2HTDwe-jTqjlr5SFjZ-TgG1c130_assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251489.RAm6F0jMft8kxIYHCqsRv2HTDwe-jTqjlr5SFjZ-TgG1c130_provenance.
- NP363058.RAKJhcEiKgdLHmaNZ_v0-tLXGpVKY5fmM0yvcNYciWMKQ130_assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363058.RAKJhcEiKgdLHmaNZ_v0-tLXGpVKY5fmM0yvcNYciWMKQ130_provenance.
- NP251487.RAI6sUndFd4_mT4IwQoKbg5B9JgKrZ7bmNxmxUZEHILZg130_assertion description "[Increased expression of E2F-1 mRNA was observed in 40% (12/30) of the gastric carcinomas and in 60% (3/5) of the colorectal carcinomas in comparison with the corresponding non-neoplastic mucosa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251487.RAI6sUndFd4_mT4IwQoKbg5B9JgKrZ7bmNxmxUZEHILZg130_provenance.